# Lurasidone

## Latuda 40mg

| TAH Drug Code      | [OLAT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLAT){:target="_blank"}                                                                                                                                                                                                                                                                                   |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Schizophrenia.                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Should be taken with food (at least 350 kcal). Schizophrenia: 40mg QD. maximum: 160mg/day. Depressive episodes of type 1 bipolar disorder: 20mg QD, the dose can be increased based on clinical response after one week of treatment. maximum: 80mg/day.                                                                                                                 |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Hypersensitivity. Concomitant w/ strong CYP3A4 inhibitors (eg, ketoconazole, clarithromycin, ritonavir, voriconazole) & inducers (eg, rifampin, St. John's wort, phenytoin, carbamazepine).                                                                                                                                                                              |
| Adverse Effects    | Akathisia, somnolence. Hypersensitivity; increased wt; insomnia, agitation, anxiety, restlessness; parkinsonism, dizziness, dystonia, dyskinesia; nausea, vomiting, dyspepsia, salivary hypersecretion, upper abdominal pain, stomach discomfort; rash, pruritus; musculoskeletal stiffness, increased blood creatine phoshokinase; increased serum creatinine; fatigue. |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/lurasidone-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                              |

